OR WAIT null SECS
December 06, 2019
The new Technology Excellence Center, located in Boston, MA, will further the company’s presence in the United States biopharma drug development landscape.
December 05, 2019
Catalent and Ethicann Pharmaceuticals have announced a partnership aimed at developing a new combination pharmaceutical-grade CBD and THC product to treat MS spasticity using Catalent’s orally disintegrating tablet technology.
December 02, 2019
Spray drying is a versatile and rapid technique that can provide companies with a suitable and scalable option to improve the solubility and bioavailability of drug products.
November 20, 2019
A new sucrose product from MilliporeSigma has reduced nanoparticle impurities.
November 08, 2019
Research examined the effects of varying excipient and polymer weight in coatings designed to optimize the release of diclofenac sodium. The goal was to release it at night to improve the treatment of rheumatoid arthritis.
November 02, 2019
PATH’s Microarray Patch Center of Excellence aims to accelerate transdermal patch technology for public health needs.
Palatability is crucial for adherence and compliance to oral drug regimens.
October 24, 2019
CHMP has recommended that Ervebo (rVSVΔG-ZEBOV-GP), a vaccine for active immunization against Ebola, be granted conditional marketing authorization in the EU.
CHMP has recommended that Baqsimi (glucagon), a non-injectable treatment for severe hypoglycemia, be granted marketing authorization in the EU.
October 17, 2019
A complete understanding of primary packaging physicochemical properties is necessary in the formulation and development of biologics.